Point72 Asia (Singapore) Pte. Ltd. Sarepta Therapeutics, Inc. Call Options Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.35 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$913 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$749 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$738 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$665 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...